Back to Screener

Healthcare

Lyell Immunopharma, Inc.(LYEL)

Live Price

Offline

$12.49

-3.92% today

1Y Change

+31.25%

Window

Jun 26, 2025 โ†’ Jun 22, 2026

Market Cap
$490.00M
Revenue Growth
-41.0%
EPS Growth
-1126.0%
Dividend Yield
0.0%

Coverage: 247 bars ยท Jun 26, 2025 โ†’ Jun 22, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Lyell Immunopharma, Inc. (LYEL) is a Healthcare stock with a market cap of $490.00M and listed on NASDAQ. The stock last traded around $12.49 and up 31.3% across the available one-year price window (Jun 26, 2025 โ†’ Jun 22, 2026). Baseline metrics include revenue growth of -41.0%, EPS growth of -1126.0%, a dividend yield of 0.0%. What stands out right now is revenue -41.0%, EPS -1126.0%, free cash flow +7.4% with operating margin -566038.9% and ROIC -70.1%. Valuation already assumes a fairly strong business story at price/sales 13498.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines LYEL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

LYEL vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

LYEL

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

LYEL Max Drawdown

-68.99%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for LYEL and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 12, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 12, 26
โ€”
Est -2.31
โ€”
โ€”
Est 4.0B
โ€”
May 12
โ€”
Mar 12, 26
โœ—
-7.68
Est -2.15
-257.2%
6.0B
Est 15.3B
-60.7%
Mar 12
โ€”
Nov 12, 25
โœ“
-2.13
Est -2.81
+24.2%
15.0B
Est โ€”
โ€”
Nov 12
โ€”
Aug 12, 25
โœ“
-2.89
Est -3.80
+23.9%
8.0B
Est 4.0B
+100.0%
Aug 12
โ€”
May 13, 25
โœ“
-3.60
Est -3.80
+5.3%
7.0B
Est โ€”
โ€”
May 13
โ€”
Mar 11, 25
โœ—
-0.72
Est -0.18
-300.0%
11.0B
Est โ€”
โ€”
Mar 11
โ€”
Nov 7, 24
โœ“
-0.17
Est -0.20
+15.0%
34.0B
Est โ€”
โ€”
Nov 7
โ€”
Aug 7, 24
โœ“
-0.18
Est -0.20
+10.0%
13.0B
Est 3.3B
+300.0%
Aug 7
โ€”
May 6, 24
โœ—
-0.24
Est -0.20
-20.0%
3.0B
Est 1.0B
+200.0%
May 6
โ€”
Feb 28, 24
โœ“
-0.20
Est -0.21
+4.8%
13.0B
Est 3.3B
+300.0%
Feb 28
โ€”
Nov 7, 23
โœ“
-0.20
Est -0.27
+25.9%
25.0B
Est 6.3B
+300.0%
Nov 7
โ€”
Aug 8, 23
โœ“
-0.26
Est -0.30
+13.3%
27.0B
Est 18.0B
+50.0%
Aug 8
โ€”
May 4, 23
โœ“
-0.27
Est -0.28
+3.6%
65.0B
Est -17.5B
+471.4%
May 4
โ€”
Feb 28, 23
โœ“
-0.03
Est -0.31
+90.3%
48.4B
Est 16128.7B
-99.7%
Feb 28
โ€”
Nov 8, 22
โœ“
-0.28
Est -0.34
+17.6%
3.0B
Est 1800.0B
-99.8%
Nov 8
โ€”
Aug 4, 22
โœ“
-0.15
Est -0.31
+51.6%
35741.0B
Est 17870.5B
+100.0%
Aug 4
โ€”
May 10, 22
โœ“
-0.28
Est -0.29
+3.5%
553.0B
Est 776.5B
-28.8%
May 10
โ€”
Mar 29, 22
โœ“
-0.18
Est -0.28
+35.7%
2822.0B
Est 2642.6B
+6.8%
Mar 29
โ€”
Nov 12, 21
โœ“
-0.20
Est -0.27
+25.9%
2755.0B
Est 3469.3B
-20.6%
Nov 12
โ€”
Aug 12, 21
โœ—
-0.89
Est -0.36
-147.2%
2628.0B
Est 2628.0B
0.0%
Aug 12
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener